MIRA

$0.53722.06%-0.0113

프리마켓: 0.54+0.00 +0.52%

Mira Pharmaceuticals Inc (MIRA)

Date: O: H: L: C: Vol:

전일 마감가:

$0.5485

열려 있는:

$0.589

하루 거래량:

132,202

상대 거래량:

0.62

시가총액:

$22.57M

수익:

순이익/손실:

-$31.37M

주가수익비율:

EPS:

-$1.44

순현금흐름:

-$4.23M

1W 성능:

-2.33%

1M 성능:

-26.42%

6M 성능:

-48.35%

1Y 성능:

-68.40%

1일 변동 폭

$0.00$0.00

1주일 범위

$0.5101$0.63

52주 변동 폭

$0.5101$1.75

Mira Pharmaceuticals Inc 주식 (MIRA) 회사 개요

명칭

Mira Pharmaceuticals Inc

부문

Healthcare

산업

Drug Manufacturers - General

전화

813-369-5150

주소

1200 BRICKELL AVENUE, MIAMI, USA

직원

다음 수익 날짜

2026-11-12

최신 SEC 제출 서류

SEC

X에서 MIRA에 대한 토론

시가총액

매출

순이익

현금흐름

주당 순 이익

Mira Pharmaceuticals Inc (MIRA) 재무 분석

기간	FY 2025	FY 2024	FY 2023
기간 종료일	2025-12-31	2024-12-31	2023-12-31
Research and development USD (M)	1.72	3.31	1.57
Operating expenses USD (M)	10.49	8.02	8.53
Income before tax USD (M)	-	-	-11.98
Net income USD (M)	-10.44	-7.85	-11.98
Basic EPS USD/shares	-1.35	-0.51	-0.64
Diluted EPS USD/shares	-1.35	-0.51	-0.64
Basic weighted shares shares (M)	23.69	15.44	18.57
Diluted weighted shares shares (M)	-	15.44	18.57

Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스

Oct 29, 2026

MIRA Pharmaceuticals reports weight loss data for SKNY-1 drug By Investing.com - Investing.com Nigeria

Oct 29, 2026

Oct 26, 2026

Stocks Rally Ahead of Busy Week as Crude Oil Prices Ease - Barchart.com

Oct 26, 2026

Alphabet Stock: 3 Reasons Why GOOGL Is a Buy Ahead of Q3 Results - Barchart.com

Oct 26, 2026

Oct 22, 2026

MIRA Pharmaceuticals Slips 7.76% to $0.63 as Support Comes Into Focus - Fade Trade - https://www.siam.in/

Oct 22, 2026

MIRA Pharmaceuticals' Oral Pain Drug Delivered Relief Comparable to Celebrex in a Three-Week Study - Barchart.com

Oct 22, 2026

Form 8K Mira Pharmaceuticals Inc For: 22 October By Investing.com - Investing.com Nigeria

Oct 22, 2026

Mira Pharmaceuticals reports positive preclinical pain study By Investing.com - Investing.com India

Oct 22, 2026

MIRA Pharmaceuticals Reports MIRA-55 Matches Celecoxib in Pain Relief in 21-Day Preclinical Study - Kalkine Media

Oct 22, 2026

Oct 21, 2026

Strategy Increased Its Preferred Stock Buyback to $3 Billion and Shares Moved Higher. What This Means for MSTR - Barchart.com

Oct 21, 2026

Oct 16, 2026

Roadzen, Inc. (RDZN) stock price, news, quote and history - Yahoo Finance UK

Oct 16, 2026

Oct 14, 2026

MIRA Pharmaceuticals, Inc.: Target Price Consensus and Analysts Recommendations | K6S | US60458C1045 - www.marketscreener.com

Oct 14, 2026

Oct 13, 2026

MIRA Pharmaceuticals (MIRA) Slips 5.81% to $0.66 as Shares Test Key Support - Relative Volume - https://www.siam.in/

Oct 13, 2026

Medical Marijuana Clinical Trial Landscape Expands as 60+ Leading Companies Accelerate Drug Development | DelveInsight - The Manila Times

Oct 13, 2026

MIRA Pharmaceuticals (MIRA) Slips 5.81% to $0.66 as Shares Test Key Support - Trend Continuation Trade - https://www.dars.gov.et/

Oct 13, 2026

Oct 06, 2026

What's Behind MIRA Pharmaceuticals, Inc.'s (MIRA) Big Moment in Cannabis Stocks? - Kalkine Media

Sep 25, 2026

Sep 24, 2026

This Under-the-Radar AI Data Center Stock Just Assigned Its Michigan Campus a Value of Up to $1.25 Billion - Barchart.com

Sep 24, 2026

Trump Just Sent Greenland Mines Stock Soaring 370%. How to Play It Here. - Barchart.com

Sep 24, 2026

McDonald’s (MCD) Stock Looks Like a Lost Cause — Until You Look at the Data - Barchart.com

Sep 24, 2026

Ralph Lauren Stock: Is RL Outperforming the Consumer Cyclical Sector? - Barchart.com

Sep 24, 2026

How Is Host Hotels & Resorts’ Stock Performance Compared to Other REIT Stocks? - Barchart.com

Sep 24, 2026

Sep 23, 2026

CoreWeave Priced an Upsized $3.7 Billion Convertible Note as Capex Spending Spikes. What That Means for CRWV Stock Fans. - Barchart.com

Sep 23, 2026

Stocks Retreat as Bond Yields Climb on Fed Rate Hike Fears - Barchart.com

Sep 23, 2026

How Is Carnival Corporation Stock Performance Compared to Other Leisure and Entertainment Stocks - Barchart.com

Sep 23, 2026

Is Marvell Stock Outperforming the S&P 500? - Barchart.com

Sep 23, 2026

Sep 22, 2026

Nebius Stock Spikes 4% on Higher Computer Prices. How to Play NBIS Stock Here. - Barchart.com

Sep 22, 2026

Why Is Natera (NTRA) Stock Soaring Today - Barchart.com

Sep 22, 2026

Stocks Supported as Crude Oil Prices Ease - Barchart.com

Sep 22, 2026

APLD’s 250MW Question: The Deal That Could Unlock Applied Digital Stock’s Next Leg Up - Barchart.com

Sep 22, 2026

Sep 21, 2026

Red Cat CEO Just Sold $1.6 Million of Stock. Wall Street Sees 144% Rally Ahead. - Barchart.com

Sep 21, 2026

How Is United Airlines' Stock Performance Compared to Other Global Jets Stocks? - Barchart.com

Sep 21, 2026

Is J.B. Hunt Transport Services Stock Outperforming the S&P 500? - Barchart.com

Sep 21, 2026

Sep 20, 2026

Nebius’s Price Hike Suggests Michael Burry Made a Mistake and Is Shorting the Best Neocloud Stock - Barchart.com

Sep 20, 2026

Sep 18, 2026

IBM Once Held Nvidia's Spot as Tech's Biggest Name. The Stock Just Crashed 25%. Here's the Comeback Case. - Barchart.com

Sep 18, 2026

Stocks Finish Mostly Higher as Crude Prices Fall - Barchart.com

Sep 18, 2026

Fluence Energy (FLNC) Stock Trades Down, Here Is Why - Barchart.com

Sep 18, 2026

Sep 17, 2026

I Sold Micron Before Q2 Earnings and It Fell 23%. Here’s Why I'm Buying Before the Next Report. - Barchart.com

Sep 17, 2026

MIRA Pharmaceuticals submits Ketamir-2 protocol for IRB review By Investing.com - Investing.com Nigeria

Sep 17, 2026

MIRA Pharmaceuticals submits Ketamir-2 protocol for IRB review By Investing.com - Investing.com UK

Sep 17, 2026

MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review - Yahoo Finance

Sep 17, 2026

A drug candidate is moving toward its first patient test for nerve pain caused by chemotherapy. MIRA targets Q1 2027. - stocktitan.net

Sep 17, 2026

Maxim Group Initiates MIRA Pharmaceuticals(MIRA.US) With Buy Rating, Announces Target Price $3.5 - Moomoo

Sep 17, 2026

Sep 16, 2026

63% of MIRA Pharmaceuticals (MIRA) shares vote to reelect board and back 2026 auditor - stocktitan.net

Sep 16, 2026

Seagate Stock Has Already Exploded. Here’s What Could Send It 99% Higher to $1,600. - Barchart.com

Sep 16, 2026

Sep 08, 2026

Nearly 300 flights are cancelled due to problems in UK air traffic control system, flight monitor Flightradar24 reports - barchart.com

Sep 08, 2026

Sep 02, 2026

This Under-the-Radar Biopharma Is Moving MIRA-55, a Non-Opioid Pain Drug That Outperformed Morphine Closer to the Clinic - Barchart.com

Sep 02, 2026

Mira advances IND-enabling studies of MIRA-55 for pain - BioWorld News

Sep 02, 2026

Is Lam Research Stock Outperforming the Nasdaq? - Barchart.com

Sep 02, 2026

MIRA와(과) 유사한 종목

Mira Pharmaceuticals Inc (MIRA)

Mira Pharmaceuticals Inc 주식 (MIRA) 회사 개요

시가총액

매출

순이익

현금흐름

주당 순 이익

Mira Pharmaceuticals Inc (MIRA) 재무 분석

Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스

MIRA Pharmaceuticals reports weight loss data for SKNY-1 drug By Investing.com - Investing.com Nigeria

Stocks Rally Ahead of Busy Week as Crude Oil Prices Ease - Barchart.com

Alphabet Stock: 3 Reasons Why GOOGL Is a Buy Ahead of Q3 Results - Barchart.com

MIRA Pharmaceuticals Slips 7.76% to $0.63 as Support Comes Into Focus - Fade Trade - https://www.siam.in/

MIRA Pharmaceuticals' Oral Pain Drug Delivered Relief Comparable to Celebrex in a Three-Week Study - Barchart.com

Form 8K Mira Pharmaceuticals Inc For: 22 October By Investing.com - Investing.com Nigeria

Mira Pharmaceuticals reports positive preclinical pain study By Investing.com - Investing.com India

MIRA Pharmaceuticals Reports MIRA-55 Matches Celecoxib in Pain Relief in 21-Day Preclinical Study - Kalkine Media

Strategy Increased Its Preferred Stock Buyback to $3 Billion and Shares Moved Higher. What This Means for MSTR - Barchart.com

Roadzen, Inc. (RDZN) stock price, news, quote and history - Yahoo Finance UK

MIRA Pharmaceuticals, Inc.: Target Price Consensus and Analysts Recommendations | K6S | US60458C1045 - www.marketscreener.com

MIRA Pharmaceuticals (MIRA) Slips 5.81% to $0.66 as Shares Test Key Support - Relative Volume - https://www.siam.in/

Medical Marijuana Clinical Trial Landscape Expands as 60+ Leading Companies Accelerate Drug Development | DelveInsight - The Manila Times

MIRA Pharmaceuticals (MIRA) Slips 5.81% to $0.66 as Shares Test Key Support - Trend Continuation Trade - https://www.dars.gov.et/

Earnings Calendar for: - Yahoo Finance

Thursday's session: gap up and gap down stocks - ChartMill

Is Hasbro Stock Underperforming the S&P 500? - barchart.com

What's Behind MIRA Pharmaceuticals, Inc.'s (MIRA) Big Moment in Cannabis Stocks? - Kalkine Media

This Under-the-Radar AI Data Center Stock Just Assigned Its Michigan Campus a Value of Up to $1.25 Billion - Barchart.com

Trump Just Sent Greenland Mines Stock Soaring 370%. How to Play It Here. - Barchart.com

McDonald’s (MCD) Stock Looks Like a Lost Cause — Until You Look at the Data - Barchart.com

Ralph Lauren Stock: Is RL Outperforming the Consumer Cyclical Sector? - Barchart.com

How Is Host Hotels & Resorts’ Stock Performance Compared to Other REIT Stocks? - Barchart.com

CoreWeave Priced an Upsized $3.7 Billion Convertible Note as Capex Spending Spikes. What That Means for CRWV Stock Fans. - Barchart.com

Stocks Retreat as Bond Yields Climb on Fed Rate Hike Fears - Barchart.com

How Is Carnival Corporation Stock Performance Compared to Other Leisure and Entertainment Stocks - Barchart.com

Is Marvell Stock Outperforming the S&P 500? - Barchart.com

Nebius Stock Spikes 4% on Higher Computer Prices. How to Play NBIS Stock Here. - Barchart.com

Why Is Natera (NTRA) Stock Soaring Today - Barchart.com

Stocks Supported as Crude Oil Prices Ease - Barchart.com

APLD’s 250MW Question: The Deal That Could Unlock Applied Digital Stock’s Next Leg Up - Barchart.com

Red Cat CEO Just Sold $1.6 Million of Stock. Wall Street Sees 144% Rally Ahead. - Barchart.com

How Is United Airlines' Stock Performance Compared to Other Global Jets Stocks? - Barchart.com

Is J.B. Hunt Transport Services Stock Outperforming the S&P 500? - Barchart.com

Nebius’s Price Hike Suggests Michael Burry Made a Mistake and Is Shorting the Best Neocloud Stock - Barchart.com

IBM Once Held Nvidia's Spot as Tech's Biggest Name. The Stock Just Crashed 25%. Here's the Comeback Case. - Barchart.com

Stocks Finish Mostly Higher as Crude Prices Fall - Barchart.com

Fluence Energy (FLNC) Stock Trades Down, Here Is Why - Barchart.com

I Sold Micron Before Q2 Earnings and It Fell 23%. Here’s Why I'm Buying Before the Next Report. - Barchart.com

MIRA Pharmaceuticals submits Ketamir-2 protocol for IRB review By Investing.com - Investing.com Nigeria

MIRA Pharmaceuticals submits Ketamir-2 protocol for IRB review By Investing.com - Investing.com UK

MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review - Yahoo Finance

A drug candidate is moving toward its first patient test for nerve pain caused by chemotherapy. MIRA targets Q1 2027. - stocktitan.net

Maxim Group Initiates MIRA Pharmaceuticals(MIRA.US) With Buy Rating, Announces Target Price $3.5 - Moomoo

63% of MIRA Pharmaceuticals (MIRA) shares vote to reelect board and back 2026 auditor - stocktitan.net

Seagate Stock Has Already Exploded. Here’s What Could Send It 99% Higher to $1,600. - Barchart.com

Nearly 300 flights are cancelled due to problems in UK air traffic control system, flight monitor Flightradar24 reports - barchart.com

This Under-the-Radar Biopharma Is Moving MIRA-55, a Non-Opioid Pain Drug That Outperformed Morphine Closer to the Clinic - Barchart.com

Mira advances IND-enabling studies of MIRA-55 for pain - BioWorld News

Is Lam Research Stock Outperforming the Nasdaq? - Barchart.com

MIRA와(과) 유사한 종목